Yamaha MT-15 V2, Fascino 125 Fi Hybrid And RayZR 125 Fi Hybrid Get New Colour Options By Sahil Siddiqui 8 Apr, 2024 5005 views These new colours are available with the existing colour schemes and ...
Legacy buyers are the holy grail for any manufacturer. Lure them in from the start, then provide stepping stones of ...
Aprilia RS 457 Price starts at Rs. 4.26 Lakh which is Rs. 2.68 Lakh costlier than base model of Yamaha MT 15 Version 2.0 priced at Rs. 1.58 Lakh. The claimed mileage of Aprilia RS ...
The 125 Duke [2018-2025] STD is powered by a 124.7 cc engine. In the 125 Duke [2018-2025]'s price range, buyers can choose to ...
Bike News Review - April 2021 Edition: In this month's Bike News I discuss the new Triumph TE-1, the new bmw R18, Lexmoto lxr 125, Aprilia RS660 vs Honda CBR600F, Ducati Streetfighter V4 S Black, ...
The Yamaha RayZR 125 Fi Street Rally will feel like a small step up from your Xoom in terms of performance while continuing to return good fuel efficiency because of its hybrid assist, stop/start ...
RX100 and RD350 looked classically gorgeous. They felt raw on the throttle and were always eager to be pushed. Back in the day, Boomers rode them; now, Gen Zs enjoy them on social media. Yamaha ...
Can't decide which bike to buy? Ask our experts and get answers to all your bikes related queries.
Yamaha Motor India has filed a trademark for the YZF-R2, hinting at the possibility of a new addition to the R-series lineup, though nothing is confirmed yet. Interestingly, soon after this ...
The Honda CB 125 Hornet I’m astride made light work of the heavy weekday traffic, even at this early hour. Despite its modest 125 cc single-cylinder engine, the CB 125 Hornet managed to stay ahead of ...
The MT-03 is one of several Yamaha motorcycles you can buy for under $5,000 if you don't include taxes or fees. The 2025 Yamaha MT-03 has a starting MSRP of $4,999, plus the $600 Destination Charge ...
JUPITER, Fla., June 9, 2025 /PRNewswire/ -- Myosin Therapeutics, Inc., a clinical-stage biotechnology company developing first-in-class therapies targeting molecular motors, today announced that the U ...